Open tender · Germany · Pharmaceutical products
Open House Originale Rabattverträge 2025-25 - Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid (Wirkstoffkombination)
In EnglishOpen House Original Discount Agreements 2025-25 - Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamid (active ingredient combination)
Techniker Krankenkasse in Germany is inviting bids for “Open House Original Discount Agreements 2025-25 - Darunavir/Cobicistat/Emtricitabine/Tenofovir alafenamid (active ingredient combination)”. Bids close on 31 October 2027, 23:58 CET. askTender lists every requirement to qualify and checks whether your company meets them.
The work
Schluss von Rabattverträgen für die Wirkstoffkombination Darunavir/Cobicistat/Emtricitabin/Tenofovir alafenamid im Open-House-Verfahren der TK.
Key facts
- Procedure
- Contract notice
Before you bid, askTender
Everything else is in your askTender account
askTender has broken this tender down into 3 requirements to qualify (3 on experience) and the 1 document a bidder must file.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: TED – Tenders Electronic Daily. © European Union, 1998–2026. Notices reused under Commission Decision 2011/833/EU. · Sources & licences